Encision co-founder resigns as executive officer
Roger Odell, co-founder of medical device company Encision (PINK:ECIA), stepped down from his roles as executive officer, chairman and executive board member. Odell, who did not cite any reason for the shift, will stay on in a non-executive role.
Read more
Cyberonics hires new emerging therapies VP
Former Valtech Cardio CEO Bruce KenKnight was tapped to be Cyberonics‘ (NSDQ:CYBX)’ new vice president of emerging therapies.
Read more
Spectranetics shuffles the deck
Paul Gardon, formerly deputy general counsel and chief intellectual property counsel for Spectranetics (NSDQ:SPNC), was appointed vice president and general counsel. Former vice president, general counsel and secretary Roger Wertheimer was named to the newly appointed position of vice president and deputy general counsel and secretary.
Read more
Hansen Medical creates a new senior sales veep role
Roberty Cathcart joined Hansen Medical (NSDQ:HNSN) in the newly created position of senior vice president of global sales, part of a move to streamline the robot-assisted surgery company’s global sales strategy.
Read more
AtriCure promotes 3
AtriCure (NSDQ:ATRC) promoted 3 employees to executive positions. Douglas Seith is now senior vice president of sales & marketing after 9 years with the firm. Michael Rogge was promoted to vice president of marketing after 7 year. Five-year veteran and Andrew Wade is the new vice president & CFO at AtriCure.
Read more